https://www.selleckchem.com/pr....oducts/sodium-oxamat
G only presented higher percent rapid-eye-movement sleep and lower daytime sleepiness compared to the MDG (both P0.05). Results were similar in the per-protocol analysis (n=127). A dietary/lifestyle intervention on top of standard care leads to greater improvements in OSA severity and symptomatology compared to standard care alone. Benefits are evident regardless of CPAP use and weight loss. Clinicaltrials.gov NCT02515357, https//clinicaltrials.gov/ct2/show/NCT02515357. Clinicaltrials.gov NCT02515357, https//clinicaltrials.go
Like
Comment
Share
